Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Medicinal Chemistry

Topics

Chemistry

Biochemistry

Medicine

Medicinal Chemistry

Organic Chemistry

Show all topics

DOI

10.1021/jm00060a017